JPS62193638A - Granular agent - Google Patents

Granular agent

Info

Publication number
JPS62193638A
JPS62193638A JP61036442A JP3644286A JPS62193638A JP S62193638 A JPS62193638 A JP S62193638A JP 61036442 A JP61036442 A JP 61036442A JP 3644286 A JP3644286 A JP 3644286A JP S62193638 A JPS62193638 A JP S62193638A
Authority
JP
Japan
Prior art keywords
granules
chitosan
powder
granular agent
acid salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61036442A
Other languages
Japanese (ja)
Inventor
Satoshi Tsujita
辻田 敏
Yasuteru Eguchi
泰輝 江口
Akitsugu Maeda
晃嗣 前田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP61036442A priority Critical patent/JPS62193638A/en
Publication of JPS62193638A publication Critical patent/JPS62193638A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Glanulating (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To hold powder for coloring and a medical effect component in a granule and to prevent the loss of its aesthetic appreciation effect and medical effect by blending inorganic acid salt and/or organic acid salt of chitosan as a mixing agent of powder to prepare a granular agent. CONSTITUTION:Chitosan is dissolved in an aq. soln. of inorganic acid and/or organic acid and various kinds of powder becoming a constitutional component of a granular agent are added to this soln. and kneaded. Then the granular agent is produced by granulating the obtained kneaded material and drying it. The blended amount of chitosan is varied by the kind and amount of the constitutional component of the granular agent but regulated to the range of 0.5-20wt%. Inorganic acid salt or organic acid salt of chitosan is salt of deacetylated substance (chitosan) of chitin. As the powdery particle blended to the granular agent, calcium secondary phosphate, insoluble sodium metaphosphate and calcium pyrophosphate, etc., are used.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は顆粒剤に関する。さらに詳しくは、水の存在下
にあっても顆粒剤を構成する粉体粒子の集結力が低下し
ない顆粒剤に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to granules. More specifically, the present invention relates to a granule in which the cohesion of powder particles constituting the granule does not decrease even in the presence of water.

〔従来の技術〕[Conventional technology]

顆粒という形態は、薬品や食品の分野等でしばしば使用
されるものである。場合によっては、水が存在していて
も顆粒がその形状を保持することが要求されることがあ
る。たとえば、歯磨剤中に配合される顆粒剤がそれに該
当する。顆粒剤を歯磨剤中に配合する目的としては、着
色用粉末を顆粒剤とすることによって歯磨剤の審美的効
果を向上させること、あるいは種々の薬効成分を歯磨剤
中に配合する場合これらの成分が研磨材等の微粒子に強
く多量に吸着されるのを防止するため等が挙げられる。
The granule form is often used in the pharmaceutical and food fields. In some cases, it may be required that the granules retain their shape even in the presence of water. For example, granules incorporated into dentifrices fall under this category. The purpose of incorporating granules into dentifrices is to improve the aesthetic effect of dentifrices by turning coloring powder into granules, or to incorporate various medicinal ingredients into dentifrices. For example, the purpose is to prevent the particles from being strongly adsorbed in large quantities by fine particles such as abrasives.

一方、顆粒剤は通常、次のような工程で製造される。On the other hand, granules are usually manufactured through the following steps.

粉体の混合→混練→造粒→乾粒→整粒 すなわち、種々の有効成分や賦形剤、着色剤等の粉体を
結合剤を含む溶液中で混練して顆粒剤とするのである。
Powder mixing → kneading → granulation → dry granulation → granulation In other words, powders of various active ingredients, excipients, colorants, etc. are kneaded in a solution containing a binder to form granules.

ここに使用される結合剤には、水溶性のものと水不溶性
のものの2種類がある。水溶性のものとしては、デンプ
ン、ゼラチン、アラビアゴム、メチルセルロース、カル
ボキシメチルセルロースナトリウム、ヒドロキシエチル
セルロース、ポリビニルピロリドン等が例示される。ま
た、水不溶性のものは、有機溶媒に溶解して使用される
が、それらには、エチルセルロース、アセチルセルロー
ス等がある。
There are two types of binders used here: water-soluble and water-insoluble. Examples of water-soluble materials include starch, gelatin, gum arabic, methylcellulose, sodium carboxymethylcellulose, hydroxyethylcellulose, and polyvinylpyrrolidone. Further, water-insoluble ones are used after being dissolved in an organic solvent, and examples thereof include ethyl cellulose and acetyl cellulose.

水溶性の結合剤を用いて作られた顆粒剤は、それを水が
存在する環境、たとえば歯磨剤生地中に配合すると、水
分により顆粒を構成する粉体の集結性が低下し、その形
状が崩壊してしまうという問題があった。
When granules made using a water-soluble binder are blended into an environment where water is present, such as in toothpaste dough, the moisture reduces the cohesiveness of the powder that makes up the granules, causing their shape to change. The problem was that it would collapse.

これに対し、水不溶性の結合剤を使用すると、前述のよ
うな集結性の低下の問題はないものの、顆粒剤の製造に
有機溶媒を使用せねばならず、人体への悪影響や火災等
の事故が懸念されることになる。
On the other hand, if a water-insoluble binder is used, although there is no problem of reduced cohesiveness as mentioned above, it requires the use of organic solvents in the production of granules, which can cause adverse effects on the human body and accidents such as fire. is a concern.

〔問題点を解決するだめの手段〕[Failure to solve the problem]

−F記の問題点を解決するだめ、本発明者らは水溶性の
結合剤を含有していても水が存在する環境下でその形状
が安定に保持される顆粒剤を得るべく、鋭意研究の結果
、本発明を完成させた。
- In order to solve the problem described in F, the present inventors conducted extensive research in order to obtain granules that stably maintain their shape in an environment where water exists even though they contain a water-soluble binder. As a result, the present invention was completed.

すなわち、本発明はキトサンの無機酸蔗塩又は/及び有
機酸塩を粉体の結合剤として配合したこと全特徴とする
顆粒剤を提供するものである。
That is, the present invention provides a granule having the following characteristics: an inorganic acid sulfate salt and/or an organic acid salt of chitosan is blended as a powder binder.

本発明で顆粒剤とは、粉体粒子どうしの集合体であり、
肉眼でその存在が確認できる程度の太きさのものを意味
する。
In the present invention, granules are aggregates of powder particles,
It means something that is so thick that its existence can be confirmed with the naked eye.

本発明顆粒剤に配合されるキトサンの無機酸塩又は有機
酸塩(以下、単にキトサン塩という)は、キチンの脱ア
セチル化物(キトサン)の塩である。
The inorganic or organic acid salt of chitosan (hereinafter simply referred to as chitosan salt) blended into the granules of the present invention is a salt of deacetylated chitin (chitosan).

ここでキチンは、カニ、エビ、昆虫などの甲殻やキノコ
やカビの細胞壁に存在するN−アセテルーD−グルコサ
ミンの重合体である。
Here, chitin is a polymer of N-acetel-D-glucosamine that exists in the shells of crabs, shrimp, insects, etc., and in the cell walls of mushrooms and molds.

キトサンは、脱アセチル化度が^い程、分子内にアミノ
基が多く、逆にアセトアミド基が少なくなる。本発明で
は、無機酸又は有機酸の希薄溶液に溶解し得る程度に脱
アセチル化したものであれば使用できるが、脱アセチル
化度が60%以上のものが好適である。
The higher the degree of deacetylation of chitosan, the more amino groups there are in the molecule, and the fewer acetamido groups there are. In the present invention, any material that has been deacetylated to the extent that it can be dissolved in a dilute solution of an inorganic or organic acid can be used, but those with a degree of deacetylation of 60% or more are preferred.

キトサン塩を調製するに際し用いる無機酸としては、塩
酸、硫酸、リン酸等が例示でき、有機酸としては、酢酸
、クエン酸、リンゴ酸、7マル酸、マレイン酸、コハク
酸、乳酸等があげられる。
Examples of inorganic acids used in preparing chitosan salt include hydrochloric acid, sulfuric acid, phosphoric acid, etc., and examples of organic acids include acetic acid, citric acid, malic acid, hexamaric acid, maleic acid, succinic acid, lactic acid, etc. It will be done.

本発明顆粒剤に配合される粉体粒子は、顆粒剤が水の存
在下で製造されるため、水や酸に不溶若しくは難溶のも
のであることが必要である。具体例としては、第2リン
酸カルシウム、不溶性メタリン酸ナトリウム、ビロリン
酸カルシウム、アルミナ、水酸化アルミニウム、炭酸カ
ルシウム、ゼオライト、無水ケイ酸、含水ケイ酸等の主
に歯磨剤の研磨剤として使用される粉体;さらに、乳糖
、結晶性セルロース、デンプン、タルク、ナイロン、ポ
リスチレン等の主として顆粒剤の賦形剤として使用され
る粉体が挙げられる。
Since the granules are manufactured in the presence of water, the powder particles added to the granules of the present invention need to be insoluble or sparingly soluble in water and acids. Specific examples include powders mainly used as abrasives in toothpaste such as dicalcium phosphate, insoluble sodium metaphosphate, calcium birophosphate, alumina, aluminum hydroxide, calcium carbonate, zeolite, anhydrous silicic acid, and hydrated silicic acid. Further examples include powders mainly used as excipients for granules, such as lactose, crystalline cellulose, starch, talc, nylon, and polystyrene.

本発明の顆粒剤は、上記の水に不溶若しくは難溶の粉体
をベースにし、キトサン塩を結合剤として構成されるが
、これらの成分以外に目的に応じて種々の物質を顆粒剤
の成分として取り入れることができる。例えば、着色す
るための各種無機あるいは有機(天然と合成の)顔料、
さらに具体的には、群青やベンガラ、酸化チタン等の無
機顔料;パプリカ色素や紫根などの食品用天然色素;赤
色3号や青色1号などの医薬品に使用可能タール系色素
およびそのレーキ類等である。
The granules of the present invention are composed of the above water-insoluble or sparingly soluble powder as a base and chitosan salt as a binder, but in addition to these ingredients, various substances may be added to the granules depending on the purpose. It can be incorporated as For example, various inorganic or organic (natural and synthetic) pigments for coloring;
More specifically, inorganic pigments such as ultramarine blue, red iron oxide, and titanium oxide; natural food pigments such as paprika pigment and purple root; tar-based pigments that can be used in pharmaceuticals such as Red No. 3 and Blue No. 1, and their lakes; be.

また、各種薬用成分、たとえば、塩酸クロルヘキシジン
、グルコン酸クロルヘキシジン、ε−アミノカプロン酸
、トラネキサム酸、ジヒドロコレスタノール、アラント
イン、アラントインクロルヒドロキシルアルミニウム、
モノフルオルリン酸ナトリウム、フン化スズ、フィチン
酸、デキストラナーゼ、ムタナーゼ、グロテアーゼ、リ
ゾチーム、塩化ナトリウム、セチルピリジニウムクロリ
ド、ビタミンE1 ビタミンEのエステル、ビタミンC
等も顆粒剤の成分に取り入れることができる。
In addition, various medicinal ingredients such as chlorhexidine hydrochloride, chlorhexidine gluconate, ε-aminocaproic acid, tranexamic acid, dihydrocholestanol, allantoin, allantoin chlorhydroxylaluminum,
Sodium monofluorophosphate, tin fluoride, phytic acid, dextranase, mutanase, grotease, lysozyme, sodium chloride, cetylpyridinium chloride, vitamin E1, ester of vitamin E, vitamin C
etc. can also be incorporated into the ingredients of granules.

これらの顔料や薬効成分が水に不溶あるいは難溶であれ
ば、これらを本発明の顆粒剤のベースにすることもでき
る。
If these pigments and medicinal ingredients are insoluble or sparingly soluble in water, they can also be used as the base of the granules of the present invention.

本発明の顆粒剤は、例えば次の方法により製造すること
ができる。すなわち、キトサンを無機酸及び/又は有機
酸の水溶液に溶解し、この溶液中に顆粒剤の構成成分と
なる各種粉体等を加えて混練する。次いで得られた混線
物を造粒、乾燥することにより製造される。造粒法とし
ては、押出し造粒法や噴霧造粒法等が利用できる。
The granules of the present invention can be produced, for example, by the following method. That is, chitosan is dissolved in an aqueous solution of an inorganic acid and/or an organic acid, and various powders, etc. that will be constituent components of the granules are added to this solution and kneaded. Next, the obtained mixed wire material is granulated and dried to produce the product. As the granulation method, extrusion granulation method, spray granulation method, etc. can be used.

本発明顆粒剤中へのキトサン塩の配合量は、各種用途に
応じて決定することができる。すなわち、キトサン塩の
配合量が多くなるにつれて、顆粒剤の崩壊強度も大きく
なるので、顆粒剤の用途によって好ましい崩壊強度とな
るようにキトサン塩の量を調整することができる。まだ
、キトサン塩に加えて、前記の各種水溶性結合剤を併用
することによっても顆粒剤の崩壊強度を調整することが
できる。例えば、本発明の顆粒剤が歯磨剤に配合するた
めのものである場合には、当該顆粒剤の崩壊強度は、顆
粒剤が歯磨剤に配合されるときはその形状が保持されて
おり、歯を磨く行為によって容易にそれが崩壊する程度
のものが好ましい。そのためのキトサン塩の配合量は、
顆粒剤の構成成分の種類や量によって異なるが、0.5
〜20重量%の範囲である。例えば平均粒径が20ミク
ロン以下の粉体を構成成分とし、脱アセチル化度60%
以上のキトサンからなるキトサン塩を用いた顆粒剤の場
合、キトサン塩の配合量は1〜5重4%であることが好
ましい。また、顆粒剤の平均直径は150〜1,000
ミクロンが適当である。
The amount of chitosan salt to be incorporated into the granules of the present invention can be determined depending on various uses. That is, as the amount of chitosan salt added increases, the disintegration strength of the granules also increases, so the amount of chitosan salt can be adjusted to provide a preferable disintegration strength depending on the use of the granules. In addition to the chitosan salt, the disintegration strength of the granules can also be adjusted by using the various water-soluble binders described above. For example, when the granules of the present invention are to be incorporated into a dentifrice, the disintegration strength of the granules is such that when the granules are incorporated into the dentifrice, their shape is maintained and It is preferable that it be easily disintegrated by the act of polishing. The amount of chitosan salt to be added for this purpose is
It varies depending on the type and amount of the constituent components of the granules, but the amount is 0.5
-20% by weight. For example, the constituent components are powders with an average particle size of 20 microns or less, and the degree of deacetylation is 60%.
In the case of granules using chitosan salt made of chitosan as described above, the amount of chitosan salt blended is preferably 1 to 5% by weight and 4%. In addition, the average diameter of the granules is 150 to 1,000.
Micron is appropriate.

〔作用及び発明の効果〕[Action and effect of invention]

キトサン塩を結合剤とする本発明の顆粒剤は、その製造
工程において水を溶媒として使用するだめ、有機溶媒を
使用する場合に必要な火災予防などの施設が不要である
という利点を有する。また、通常の水溶性結合剤を使用
した顆粒剤のように水の存在下、たとえば歯磨剤中の水
分によってその形状が崩壊することがない。従って、歯
磨剤中において着色用粉末や薬効成分を顆粒中に保持せ
しめ、その審美効果、薬効の喪失を防止することができ
る。
The granules of the present invention using chitosan salt as a binder have the advantage that since water is used as a solvent in the manufacturing process, there is no need for facilities such as fire prevention, which are required when organic solvents are used. Furthermore, unlike granules using ordinary water-soluble binders, their shape does not collapse in the presence of water, for example, due to moisture in toothpaste. Therefore, it is possible to retain the coloring powder and medicinal ingredients in the granules in the dentifrice, thereby preventing the aesthetic effect and medicinal effect from being lost.

〔実施例〕〔Example〕

次に実施例を挙げて本発明を説明する。 Next, the present invention will be explained with reference to Examples.

実施例1 種々の結合剤を用いて顆粒剤を製造し、これを水中で機
械的に攪拌したときの顆粒形状保持力について試験した
Example 1 Granules were produced using various binders and tested for granule shape retention when mechanically stirred in water.

(1)材料 ■粉体 第2リン酸カルシウム・2水和塩(東洋ス■結合剤 ・キトサン酢酸塩〔キトサン(片倉チンヵリン■製、脱
アセチル度80%以上)を1%酢酸水溶液に溶解して調
製〕 ・カルボキシメチルセルロースナトリウム〔第一工業製
薬■製、商品名セロゲンF−8EXを精製水に溶解して
使用: CMC−Naと略す〕・ヒドロキシエチルセル
ロース〔ダイセル化学工業■製、商品名f(EC−ユニ
セルQP−4400Hを精製水に溶解して使用、HEC
と略す〕 (2)顆粒剤の製法 第2リン酸カルシウム・2水和塩100重量部に対し、
結合剤が3,5重量部になる様に結合剤の溶液を加えて
十分に混練し、これを20メツシユの篩を通して押出し
造粒後、90℃で3時間加熱乾燥して顆粒剤を製造した
。その後、粒子径を選別し、25メツシユの篩を通過し
3゜メツシュの篩に捕捉されたものを以下の実験に使用
した。
(1) Materials ■ Powdered dicalcium phosphate dihydrate salt (Toyosu ■ Binder / Chitosan acetate [Prepared by dissolving chitosan (manufactured by Katakura Chinkarin ■, deacetylation degree 80% or more) in 1% acetic acid aqueous solution ] ・Carboxymethylcellulose sodium [manufactured by Daiichi Kogyo Seiyaku ■, trade name Celogen F-8EX dissolved in purified water: abbreviated as CMC-Na] ・Hydroxyethyl cellulose [manufactured by Daicel Chemical Industries ■, trade name f (EC- Use Unicell QP-4400H dissolved in purified water, HEC
(2) Manufacturing method of granules For 100 parts by weight of dicalcium phosphate dihydrate,
A binder solution was added so that the binder amount was 3.5 parts by weight, and the mixture was thoroughly kneaded, extruded through a 20-mesh sieve, granulated, and heated and dried at 90°C for 3 hours to produce granules. . Thereafter, the particle size was selected, and the particles that passed through a 25 mesh sieve and were captured on a 3° mesh sieve were used in the following experiment.

(3)顆粒剤の形状保持力評価方法 水中における顆粒剤の形状保持力を評価するために第1
0改正日本薬局方に規定された崩壊試験機(富山産業株
式会社製)を用いた。まず顆粒剤50■を補助筒に秤り
取り、これを50mMクエン酸リン酸緩衝液(pH5,
0〜s、o 。
(3) Evaluation method for shape retention of granules In order to evaluate the shape retention of granules in water,
A disintegration tester (manufactured by Toyama Sangyo Co., Ltd.) specified in the Japanese Pharmacopoeia 0 revised edition was used. First, weigh out 50 μg of granules into an auxiliary tube, add this to 50 mM citrate phosphate buffer (pH 5,
0~s, o.

37℃)に浸漬し、1分間に45ストロークの頻度で上
下運動させた。20分間作動した後、補助筒中に、残存
する顆粒の量を観察して以下の基準により形状保持力を
評価した。
37° C.) and moved up and down at a frequency of 45 strokes per minute. After operating for 20 minutes, the amount of granules remaining in the auxiliary tube was observed and the shape retention was evaluated according to the following criteria.

評価基準: ○:  良 好 (補助筒に顆粒が大部分残存)Δ: 
 不 良  (補助筒に顆粒が2程度残存)×:  極
めて不良(補助筒に顆粒がほとんど残存せず)結果を表
1に示す。その結果、水溶性結合剤であるC MC−N
aやHECを使用した顆粒剤は、形状保持力が劣ってい
るが、キトサン酢酸塩を使用した本発明顆粒剤は、優れ
た形状保持力を有している。
Evaluation criteria: ○: Good (Most of the granules remain in the auxiliary cylinder) Δ:
Poor (about 2 granules remained in the auxiliary cylinder) ×: Extremely poor (almost no granules remained in the auxiliary cylinder) The results are shown in Table 1. As a result, the water-soluble binder C MC-N
Granules using a or HEC have poor shape retention, but the granules of the present invention using chitosan acetate have excellent shape retention.

さらにキトサンの塩酸塩、リン酸塩、クエン酸塩及びコ
ハク酸塩を用いて同様の試験を行ったところ、はぼ同一
の結果が得られた。
Furthermore, when similar tests were conducted using chitosan hydrochloride, phosphate, citrate, and succinate, almost identical results were obtained.

表  1 実施例2 4A型ゼオライト粉末(花王■製、平均粒径2ミクロン
)100重量部と、着色剤として群青(和光紬薬■製)
1重畦部をよく混合した。これにキトサン(実施例1と
同じ)3重量部を1パーセント酢酸水溶液に溶解して加
え、これらを混練した。この粘土状の混合物を20メツ
シユの篩で押出し造粒し、90℃で3時間乾燥して顆粒
剤とした。さらに20メツシユの篩を通して大粒径のも
のを除去し、また80メツシユの篩で粉末を除いて青色
の顆粒剤を得た。この顆粒剤を歯磨剤に配合すれば、ゼ
オライトの歯石予防効果と群青の審美性を得ることがで
きる。
Table 1 Example 2 100 parts by weight of 4A type zeolite powder (manufactured by Kao ■, average particle size 2 microns) and ultramarine blue (manufactured by Wako Tsumugi Pharmaceutical ■) as a coloring agent.
The single layer ridge was thoroughly mixed. To this was added 3 parts by weight of chitosan (same as in Example 1) dissolved in a 1% acetic acid aqueous solution, and these were kneaded. This clay-like mixture was granulated by extrusion through a 20-mesh sieve, and dried at 90° C. for 3 hours to obtain granules. Further, large particles were removed through a 20-mesh sieve, and powder was removed through an 80-mesh sieve to obtain blue granules. By incorporating this granule into a dentifrice, it is possible to obtain the tartar prevention effect of zeolite and the esthetics of ultramarine blue.

実施例3 アラントインクロルヒドロキシアルミニウム(用便ファ
インケミカル(掬製)50重量部に無水ケイ酸10重量
部とパプリカ色素(水和物産■製)1重量部を混合し、
これにキトサン(実施例1と同じ)2電歇部を1パーセ
ント酢酸水溶液に溶解して加え、混練した。この粘土状
の混合物を20メンシユの篩で押出し造粒し、90℃3
時間加熱乾燥して顆粒剤とし、さらに20メツシユの篩
を通して大粒径のものを除去し、また80メツシユの篩
で粉末を除いて橙赤色の顆粒剤を得た。この顆粒剤を歯
磨剤に配合すればアラントインクロルヒドロキシアルミ
ニウムの歯肉炎予防効果とパプリカ色素の審美性を得る
ことができる。
Example 3 10 parts by weight of silicic anhydride and 1 part by weight of paprika pigment (manufactured by Hydrate Bussan ■) were mixed with 50 parts by weight of allantoin chlorhydroxyaluminum (Yobin Fine Chemicals (manufactured by Kiki),
Two parts of chitosan (same as in Example 1) dissolved in a 1% acetic acid aqueous solution was added to this and kneaded. This clay-like mixture was extruded through a 20-mesh sieve and granulated at 90°C.
The mixture was heated and dried for a period of time to form granules, which were then passed through a 20-mesh sieve to remove large particles, and then through an 80-mesh sieve to remove powder to obtain orange-red granules. By incorporating this granule into a dentifrice, it is possible to obtain the gingivitis preventive effect of allantoin chlorhydroxyaluminum and the aesthetic properties of paprika pigment.

実施例4 フィチン酸ナトリウム(シグマ社製)1重量部に乳糖5
0重量部を混合し、これにキトサン(実施例1と同じ)
2重量部を1パーセント酢酸水溶液に溶解して加え、混
練した。この粘土状の混合物を20メツシユの篩で押出
し造粒し、90℃3時間加熱乾燥して顆粒剤を得だ。さ
らに20メツシユの篩を通して大粒径のものを除去し、
また80メツシユの篩で粉末を除いて白色の顆粒剤を得
た。
Example 4 5 parts of lactose in 1 part by weight of sodium phytate (manufactured by Sigma)
0 parts by weight and chitosan (same as Example 1)
Two parts by weight were dissolved in a 1% acetic acid aqueous solution and added, followed by kneading. This clay-like mixture was granulated by extrusion through a 20 mesh sieve, and dried by heating at 90°C for 3 hours to obtain granules. Furthermore, large particles are removed through a 20-mesh sieve.
Further, powder was removed using an 80-mesh sieve to obtain white granules.

この顆粒剤を歯磨剤に配合すれば、フィチン酸ナトリウ
ムの歯石予防効果を得ることができる。
If this granule is added to a dentifrice, the tartar preventive effect of sodium phytate can be obtained.

参考例1 実施例2〜4で得られた顆粒剤を下記に示した歯磨剤生
地1および2の98重量部に2重量部添加し、室温にて
10分間脱気攪拌して顆粒剤配合歯磨剤を製造した。こ
の時、実施例2〜4の顆粒剤はいずれも形状が良好に保
持されていた。また、この顆粒剤配合歯磨剤をラミネー
トチューブに充填し、40°Cにて30日間保存する加
速試験を行ったところ、保存後にも顆粒剤の形状は完全
に保持されていた。
Reference Example 1 2 parts by weight of the granules obtained in Examples 2 to 4 were added to 98 parts by weight of dentifrice materials 1 and 2 shown below, and the mixture was deaerated and stirred at room temperature for 10 minutes to produce a granule-containing toothpaste. The drug was manufactured. At this time, the granules of Examples 2 to 4 all maintained their shapes well. Further, when an accelerated test was carried out in which the dentifrice containing granules was filled into a laminated tube and stored at 40°C for 30 days, the shape of the granules was completely retained even after storage.

く歯磨剤生地1〉 第2リン酸カルシウム・2水和塩    40重量係グ
リセリン             1070%ソルビ
トール          14カルボキシメチルセル
ロースナトリウム  2ラウリル硫酸ナトリウム   
       1.5サツカリンナトリウム     
      0.2香  料            
      0.8精製水          適量 計100重量% 〈歯磨剤生地2〉 無水ケイ酸              20重竜チグ
リセリン            3070%ンルビト
ール          30カルボキシメチルセルロ
ースナトリウム  2ラウリル硫酸ナトリウム    
      1.5サツカリンナトリウム      
     0.1香  料             
     0.7精製水          適量 計100重i% 以上
Toothpaste fabric 1> Dibasic calcium phosphate dihydrate salt 40 Glycerin by weight 1070% sorbitol 14 Sodium carboxymethyl cellulose 2 Sodium lauryl sulfate
1.5 Satucalin Sodium
0.2 fragrance
0.8 Purified water Appropriate amount 100% by weight <Toothpaste dough 2> Silicic anhydride 20 Heavy tiglycerin 3070% Nlubitol 30 Sodium carboxymethyl cellulose 2 Sodium lauryl sulfate
1.5 Satucalin Sodium
0.1 fragrance
0.7 Purified water appropriate amount 100% by weight or more

Claims (1)

【特許請求の範囲】 1、キトサンの無機酸塩又は/及び有機酸塩を粉体の結
合剤として配合したことを特徴とする顆粒剤。 2、顆粒剤が歯磨配合用である特許請求の範囲第1項記
載の顆粒剤。
[Scope of Claims] 1. A granule comprising an inorganic acid salt and/or an organic acid salt of chitosan as a binder for powder. 2. The granule according to claim 1, which is for use in toothpaste formulation.
JP61036442A 1986-02-20 1986-02-20 Granular agent Pending JPS62193638A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61036442A JPS62193638A (en) 1986-02-20 1986-02-20 Granular agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61036442A JPS62193638A (en) 1986-02-20 1986-02-20 Granular agent

Publications (1)

Publication Number Publication Date
JPS62193638A true JPS62193638A (en) 1987-08-25

Family

ID=12469922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61036442A Pending JPS62193638A (en) 1986-02-20 1986-02-20 Granular agent

Country Status (1)

Country Link
JP (1) JPS62193638A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009102274A (en) * 2007-10-24 2009-05-14 Kao Corp Method for producing dentifrice granule containing non-cationic germicide
JP2009242241A (en) * 2007-11-21 2009-10-22 Kao Corp Dentifrice

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50123815A (en) * 1974-02-11 1975-09-29
JPS5348190A (en) * 1976-10-13 1978-05-01 Kobe Steel Ltd Servo control system
JPS56136287A (en) * 1980-03-26 1981-10-24 Nec Corp Electron beam welding machine in air
JPS59101416A (en) * 1982-11-30 1984-06-12 Lion Corp Oral cavity composition
JPS59152312A (en) * 1983-02-18 1984-08-31 Lion Corp Oral cavity composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50123815A (en) * 1974-02-11 1975-09-29
JPS5348190A (en) * 1976-10-13 1978-05-01 Kobe Steel Ltd Servo control system
JPS56136287A (en) * 1980-03-26 1981-10-24 Nec Corp Electron beam welding machine in air
JPS59101416A (en) * 1982-11-30 1984-06-12 Lion Corp Oral cavity composition
JPS59152312A (en) * 1983-02-18 1984-08-31 Lion Corp Oral cavity composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009102274A (en) * 2007-10-24 2009-05-14 Kao Corp Method for producing dentifrice granule containing non-cationic germicide
JP2009242241A (en) * 2007-11-21 2009-10-22 Kao Corp Dentifrice

Similar Documents

Publication Publication Date Title
JP3560244B2 (en) Solid drug dosage forms having a two-stage release over an extended period of time and their manufacture
DE3874393T2 (en) BALL FOR CONTROLLED RELEASE OF A MEDICINAL PRODUCT.
CA2072933C (en) Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients
DE69407404T2 (en) SOLID PREPARATION WITH HIGH RELEASE, THEIR PRODUCTION AND USE
DE69914928T2 (en) POLYMER COMPLEXES OF GLUCURONOGLUCANS
DE60037653T2 (en) GELATINE-FREE SCHELL DISPERSING DOSE FORMS
CA2257890C (en) Liquisolid systems and methods of preparing same
CA2556514C (en) Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
US2484637A (en) Powdered ointment base of methyl cellulose and sorbitol
DE69020541T2 (en) GRANULATES WITH HIGH IBUPROFEN CONTENT.
CN1391465A (en) Coating
PT92002B (en) PROCESS FOR THE PREPARATION OF DISPENSABLE FORMULATIONS CONTAINING DICLOFENAC
DE10003757A1 (en) Ibuprofen drug preparation
CZ300908B6 (en) Tablet containing levothyroxine natrium and process for preparing thereof
JPH05320045A (en) Spray drying method for manufacturing medicine powder composition being compressable directly to tablet
DE2854651A1 (en) COATING AGENTS FOR SOLID DRUGS
JPS62193638A (en) Granular agent
DE69733752T2 (en) DRUGS CONTAINING OXAPROCINE SODIUM SALT, CALIUM SALT, OR TRIS (HYDROXYMETHYL) AMINOMETHANE SALT
CA2136607C (en) Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer
US2883327A (en) Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof
FI89455C (en) Process for the preparation of a pharmaceutical composition
KR100267525B1 (en) Cytarabine ocfosfate hard capsule
JPH09110663A (en) Gel capsule blended with oil soluble component, its production and composition for oral cavity
JPH02704A (en) Pharmaceutical composition improved in elution property
CA2054526A1 (en) Controlled release formulations